Innovation New Jersey
  • Home
  • Our Coalition
    • Contact Us
  • News
  • Resources
    • State Supports
    • Federal Supports
    • Higher Ed Supports
  • Join Us

Innovation News

Everything Innovation. Everything New Jersey.
Follow us and stay connected.

Hackensack edges Morristown for state's top hospital in prestigious U.S. News rankings

8/4/2015

0 Comments

 
Hackensack, NJ - According to Tom Bergeron of NJBiz, "Hackensack University Medical Center was once again named the top hospital in New Jersey by the prestigious U.S. News & World Report Best Hospitals rankings, which were released Tuesday morning. Hackensack was nationally ranked in five of the identified specialties and rated “high performing” in six others, helping it earn the No. 4 overall honor in the New York City area."

Read More
0 Comments

Rutgers Research Finds Promising Therapy for Muscular Dystrophy Based on Adult Stem Cells

8/4/2015

1 Comment

 
New Brunswick, NJ - A new study recently published in the journal ACS Nano revealed a new technique to trigger muscle cell differentiation from adult stem cells using a genetic approach. The study is entitled “Inducing Stem Cell Myogenesis Using NanoScript” and was conducted by researchers at Rutgers, The State University of New Jersey in the United States and the Kyoto University in Japan.

Read More
1 Comment

Rowan gets $2.55M grand to enhance geriatric health

8/4/2015

0 Comments

 
Stratford, NJ - According to Emily Bader of NJBiz, "Rowan University School of Osteopathic Medicine announced Friday that it has received a $2.55 million grant from the Health Resources Services Administration to improve geriatric health by establishing the New Jersey Geriatrics Workforce Enhancement Program. The grant will be used to train and equip health care providers statewide, according to Dr. Thomas Cavalieri, dean of the Rowan University School of Osteopathic Medicine."

Read More
0 Comments

Merck buys Israeli biopharma firm for $95M

8/4/2015

0 Comments

 
Kenilworth, NJ - According to Eric Strauss of NJBiz, "Merck is acquiring an Israeli biopharmaceutical company for $95 million in cash, the drugmaker announced Tuesday. The Kenilworth-based company’s deal for cCAM Biotherapeutics, which is focused on cancer immunotherapies, could potentially include up to $510 million in milestone payments, it said."

Read More
0 Comments

Rutgers Cancer Institute of NJ Physicians Named Among Tops by 'Newsweek'

8/4/2015

0 Comments

 
New Brunswick, N.J. – Several physicians at Rutgers Cancer Institute of New Jersey have been named as a ‘Top Cancer Doctor’ by Newsweek magazine.  Newsweek just released the list of the nation’s top physicians for cancer care in conjunction with Castle Connolly Medical Ltd., which publishes America’s Top Doctors. Based on peer nominations, attributes such as board certification, clinical skills, training, years in practice, administrative posts, achievements and other criteria are reviewed and assessed by a physician-led research team assembled by Castle Connolly.  According to Castle Connolly, nearly 100,000 nominations are received each year for the honor. In New Jersey alone, 40 Top Cancer Doctors were named to the national list – nine are from the Cancer Institute of New Jersey.

Read More
0 Comments

House Delays Action on Patent Reform

8/4/2015

0 Comments

 
Washington D.C. - Opposition to H.R. 9, the Innovation Act, has successfully removed the patent reform legislation from the House's pre-recess schedule. The collective voice of the life sciences community, including BioNJ and BIO, was raised in overwhelming opposition to the current version of the bill, which does not provide adequate reform to the IPR system of patent challenges at the U.S. Patent & Trademark Office (PTO).

Read More
0 Comments

Internet of Medical Things Addresses CyberSecurity Issues Facing Pharmas and Device Developers 

8/4/2015

1 Comment

 
Tinton Falls, NJ - At the Internet of Medical Things speakers from Johnson & Johnson, the FDA, Sage Bionetworks, and WAM Consulting Group presented their perspectives on issues key to developing safeguards for drug development data, patient records, and medical devices. Dr. Suzanne Schwartz, the FDA’s Director for Emergency Preparedness, addressed the agency’s approach to building internal communications and public­ private partnerships to enhance cybersecurity throughout the healthcare system. While it’s not always easy to find a “front door” for collaborating with the FDA, she mentioned National Healthcare & Public Health Critical Infrastructure Protection (http://www.nhisac.org/). 

Read More
1 Comment

NJ Resources Support Serial Entrepreneur David Fischell’s  Mission to Create Life-Saving Medical Devices

8/4/2015

0 Comments

 
Trenton, NJ - The New Jersey Economic Development Authority (EDA) continues its series highlighting how entrepreneurs and investors are helping to build New Jersey’s technology ecosystem. Serial entrepreneur Dr. David Fischell, of Fair Haven, has founded and led more than a dozen medical device companies to success in the last 20 years. To Fischell, developing medical devices is a family affair. David, along with his father Dr. Robert Fischell, a physicist, and his brother Dr. Tim Fischell, a cardiologist, started New Providence-based Svelte Medical Systems in 2007.

Read More
0 Comments

Rutgers Finds Overeating Caused by a Hormone Deficiency in Brain

7/27/2015

1 Comment

 
New Brunswick, NJ - If you find yourself downing that extra piece of chocolate fudge cake even though you're not hungry, it might be the absence of a hormone in your brain that's causing you to overeat purely for pleasure. In a new Rutgers Robert Wood Johnson Medical School study published in Cell Reports, researchers found that when the hormone glucagon like peptide-1 (GLP-1) was reduced in the central nervous system of laboratory mice, they overate and consumed more high fat food.

Read More
1 Comment

Merck Marks 30-Year Milestone in Commitment to Innovation and Care in HIV/AIDS

7/27/2015

0 Comments

 
Kenilworth, NJ - Merck, known as MSD outside the United States and Canada, announced today that the company's commitment to HIV and AIDS, which started with a research and development program initiated in the mid-1980s during the early years of the epidemic, is now entering its fourth decade. To commemorate Merck's 30 years of commitment in this area, the company is launching a new effort, “Positively Committed.” The campaign highlights the company’s contributions, including the development of innovative therapies to address the unmet medical needs of people infected with HIV-1.

Read More
0 Comments

Bristol-Myers Squibb Receives U.S. FDA Breakthrough Therapy Designation 

7/27/2015

0 Comments

 
Princeton, NJ - Bristol-Myers Squibb Company announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to the investigational compound BMS-663068 when used in combination with other antiretroviral (ARV) agents for the treatment of HIV-1 infection in heavily treatment-experienced adult patients. BMS-663068 is an oral prodrug of the molecule BMS-626529 and first-in-class HIV-1 attachment inhibitor. The attachment inhibitor is designed to work differently than entry inhibitors, a current class of drugs that targets co-receptors’ activity or fusion after HIV attaches to the CD4+ host cell. BMS-663068 is thought to work at an earlier point in the replication process to prevent the virus’ initial interaction with immune cells entirely, and thus blocks its entry into the cell.

Read More
0 Comments

Need another reason to understand why the Rutgers-UMDNJ merger was so big? Listen to the dean of the medical school

7/27/2015

0 Comments

 
Newark, NJ - According to Tom Bergeron of NJBiz, "Dr. Robert Johnson had been associated with UMNDJ for much of his life. And he's the first to admit that when he heard the school was merging with Rutgers University, he didn't think it would make much of a difference — other than changing a few signs, he joked.

Read More
0 Comments

Educated Workforce Helps Attract Scientist-Turned-Entrepreneur in NJ

7/27/2015

0 Comments

 
Trenton, NJ - The New Jersey Economic Development Authority (EDA) continues its series highlighting how entrepreneurs and investors are helping to build New Jersey’s technology ecosystem: In 1999, scientist-turned-entrepreneur Navneet Puri earned his PhD in Pharmaceutical Sciences from Rutgers University and went on to found InnoPharma, Inc. in Piscataway just a few years later. The research and development pharmaceutical company, focused on developing complex generic and innovative specialty products in injectable and ophthalmic dosage forms,   was ultimately acquired by pharmaceutical giant Pfizer last year. Under Puri’s leadership, InnoPharma had more than 30 products in various stages of development, including 10 generic products that had received Food and Drug Administration approval.

Read More
0 Comments

Stockton and Philadelphia Universities Launch Joint PA Program

7/20/2015

0 Comments

 
Galloway Township, NJ – Stockton University today welcomed the inaugural group of students in the Atlantic City cohort of Philadelphia University’s Master of Science in Physician Assistant Studies program. Stockton and Philadelphia University (PhilaU) are partnering with Reliance Medical Group to offer this Atlantic City-based program in a growing field of the health sciences. 

Read More
0 Comments

Celgene to Acquire Receptos

7/20/2015

0 Comments

 
Summit, NJ – According to New Jersey Business Magazine, “Celgene Corporation and San Diego-based Receptos, Inc. sign a definitive agreement in which Celgene has agreed to acquire Receptos. Under the terms of the merger agreement, Celgene will pay $232.00 per share in cash, or a total of approximately $7.2 billion, net of cash acquired.”

Read More
0 Comments
<<Previous
Forward>>
    Do not miss a single innovative moment and sign up for our newsletter!
    Weekly updates


    Categories

    All
    3D Printing
    Academia
    Acquisitions
    Aerospace
    Agriculture
    AIDS
    Algae
    Alumni
    Animals
    Architecture
    Astrophysics
    Autism
    Awards
    Big Data
    Bioethics
    Biofuel
    Biomedical
    BioNJ
    Bioterrorism
    Bit Coins
    Brain Health
    Business
    Camden
    Cancer
    CCollege
    Cellular
    Centenary
    Chemistry
    ChooseNJ
    Climate Change
    Clinical Trials
    Cloud Tech
    Collaboration
    Computing
    Congress
    Coriell
    Council On Innovation
    Crowdfunding
    Cybersecurity
    DARPA
    Defense
    Degree
    Dementia
    Dental Health
    DOC
    DOD
    DOE
    Drew
    Drones
    Drug Creation
    Einstein's Alley
    Electricity
    Energy
    Engineering
    Entrepreneurship
    Environmental
    FAA
    Fairleigh Dickinson
    FDA
    Federal Budget
    Federal Government
    Federal Labs
    Federal Program
    Finance
    Food Science
    Fort Monmouth
    Fuel Cells
    Funding
    Genome
    Geography
    Geology
    Global Competition
    Google
    Governor Christie
    Grant
    Hackensack
    HackensackUMC
    Healthcare
    Health Care
    HHS
    HINJ
    Hospitals
    Immigration
    Incubator
    Infrastructure
    International
    Internet
    Investor
    IoT
    IP
    IT
    Jobs
    Johnson & Johnson
    K-12
    Kean
    Kessler
    Legislation
    Logistics
    Manufacturing
    Medical Devices
    Med School
    Mental Health
    Mentor
    Microorganisms
    Molecular Biology
    Montclair
    NAS
    Neuroscience
    Newark
    New Jersey
    NIFA
    NIH
    NIST
    NJBDA
    NJBIA
    NJ Chemistry Council
    NJCU
    NJDOLWD
    NJEDA
    NJEDge
    NJHF
    NJII
    NJIT
    NJMEP
    NJPAC
    NJPRO
    NJTC
    Nonprofit
    NSF
    OpEd
    Open Data
    OSHE
    OSTP
    Parasite
    Patents
    Paterson
    Patients
    Perth Amboy
    Pharma
    POTUS
    PPPL
    Princeton
    Prosthetics
    Ranking
    Rare Disease
    R&D Council
    Report
    Resiliency
    Rider
    Robotics
    Rowan
    Rutgers
    SBA
    Seton Hall
    Siemens
    Smart Car
    Smart Cities
    Software
    Solar
    Space
    SSTI
    Startup
    State Government
    STEM
    Stevens
    Stockton
    Subatomic
    Supports
    Sustainability
    Taxes
    TCNJ
    Teachers
    Telecom
    Therapy
    Thermodynamics
    Transportation
    Undergraduate
    USEDA
    Verizon
    Video Game
    Virtual Reality
    Water
    WHO
    William Paterson
    Women In STEM
    Workforce Development

Powered by Create your own unique website with customizable templates.